GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Compares the Roundhill GLP-1 & Weight Loss ETF (OZEM) and the newer REX Peptide ETF (PEPT), examining holdings, fees, and overlap as GLP-1 drug demand from Eli Lilly and Novo Nordisk continues to grow.
MarketBeat ·